Bermudian-based Atlantic Medical International has expanded its distribution agreement with Michigan-headquartered Rockwell Medical.

AMI is a supplier of medical products and equipment for the acute and continuing care markets.

The company has been a distributor of Rockwell Medical products since 2022 at which time the two parties signed a five-year distribution agreement with the option to extend the agreement.

Rockwell Medical said the amended distribution agreement expands the list of haemodialysis products that AMI is purchasing from the company, includes purchasing commitments, and generates a profit margin consistent with Rockwell Medical's gross margin guidance for 2024.

“We are excited to build upon our relationship with Rockwell Medical by expanding our supply agreement," said Chris Merritt, general manager at AMI.

"This updated distribution agreement with Rockwell Medical affords us the ability to serve and deliver more high-quality, life-sustaining products to the fragile dialysis population in Bermuda."

Rockwell Medical also announced a new five-year distribution agreement with BioNuclear, which is based in the Dominican Republic.

In the aggregate, these agreements are expected to generate approximately $1 million in annual revenues for the company, Rockwell said.

"The global reach of our haemodialysis concentrates products continues to grow," said Tim Chole, senior vice-president, sales and marketing at Rockwell Medical.

"Through distribution arrangements such as these with BioNuclear and AMI, we continue to execute against our strategy and vision to become the leading supplier of haemodialysis concentrates worldwide."